DK1455802T3 - Anvendelser af chitosanoligosaccharider - Google Patents

Anvendelser af chitosanoligosaccharider

Info

Publication number
DK1455802T3
DK1455802T3 DK02787257T DK02787257T DK1455802T3 DK 1455802 T3 DK1455802 T3 DK 1455802T3 DK 02787257 T DK02787257 T DK 02787257T DK 02787257 T DK02787257 T DK 02787257T DK 1455802 T3 DK1455802 T3 DK 1455802T3
Authority
DK
Denmark
Prior art keywords
mixtures
chitosanol
oligosaccharides
applications
present
Prior art date
Application number
DK02787257T
Other languages
English (en)
Inventor
Isabelle Boucher
Serge Brunet
Original Assignee
Dnp Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4170829&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1455802(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dnp Canada Inc filed Critical Dnp Canada Inc
Application granted granted Critical
Publication of DK1455802T3 publication Critical patent/DK1455802T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
DK02787257T 2001-12-14 2002-12-16 Anvendelser af chitosanoligosaccharider DK1455802T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2364924 2001-12-14
PCT/CA2002/001952 WO2003051376A1 (en) 2001-12-14 2002-12-16 Chitosan oligosaccharides and uses thereof

Publications (1)

Publication Number Publication Date
DK1455802T3 true DK1455802T3 (da) 2009-02-16

Family

ID=4170829

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02787257T DK1455802T3 (da) 2001-12-14 2002-12-16 Anvendelser af chitosanoligosaccharider

Country Status (10)

Country Link
US (2) US20050004057A1 (da)
EP (1) EP1455802B1 (da)
AT (1) ATE411032T1 (da)
AU (1) AU2002351583A1 (da)
DE (1) DE60229431D1 (da)
DK (1) DK1455802T3 (da)
ES (1) ES2315417T3 (da)
PT (1) PT1455802E (da)
SI (1) SI1455802T1 (da)
WO (1) WO2003051376A1 (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1229940T3 (da) * 1999-11-15 2014-08-18 Piramal Healthcare Canada Ltd Temperaturstyret og ph-afhængig selvgelerende, vandig biopolymeropløsning
US20030158302A1 (en) * 1999-12-09 2003-08-21 Cyric Chaput Mineral-polymer hybrid composition
ATE243049T1 (de) * 1999-12-09 2003-07-15 Biosyntech Canada Inc Mineral-polymer hybrid-zusammensetzung
US20030206958A1 (en) * 2000-12-22 2003-11-06 Cattaneo Maurizio V. Chitosan biopolymer for the topical delivery of active agents
IL153490A0 (en) * 2000-06-29 2003-07-06 Biosyntech Canada Inc Composition and method for the repair and regeneration of cartilage and other tissues
WO2002040070A2 (en) * 2000-11-15 2002-05-23 Bio Syntech Canada Inc. Method for restoring a damaged or degenerated intervertebral disc
BE1014638A6 (fr) * 2002-02-12 2004-02-03 Univ Liege Methode de preparation de derives de la paroi cellulaire a partir de biomasse.
US20060141046A1 (en) * 2004-05-06 2006-06-29 Ivrea Pharmaceuticals, Inc. Particles for the delivery of active agents
AU2005240189A1 (en) * 2004-05-06 2005-11-17 Ivrea Pharmaceuticals, Inc. Particles for the delivery of active agents
WO2006054319A2 (en) * 2004-11-19 2006-05-26 Genis Ehf. Use of chitooligomer formulations to modify abnormal activity of chitinase like proteins
IS7572A (is) * 2004-11-29 2006-05-30 Genis Ehf Aðferð og efni til lækninga
DE102004060246A1 (de) * 2004-12-15 2006-07-06 Cognis Ip Management Gmbh Verwendung von Chitosan gegen Juckreiz
CA2628313A1 (en) * 2005-11-04 2007-05-31 Bio Syntech Canada Inc. Composition and method for efficient delivery of nucleic acids to cells using chitosan
EP2001491B1 (en) 2006-04-05 2016-06-08 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Anti-allergy compositions
WO2008048076A1 (en) * 2006-10-20 2008-04-24 Amorepacific Corporation A composition for treatment of atopic dermatitis comprising glucosamine and derivatives thereof and a method for treatment of atopic dermatitis using them
US20080182819A1 (en) * 2007-01-29 2008-07-31 Act Iii Licensing, Llc Chitosan compositions and methods for using chitosan compositions in the treatment of health disorders
EP1958638A1 (en) * 2007-02-14 2008-08-20 Polichem S.A. Use of chitosans to increase nail growth rate
EP1958639A1 (en) * 2007-02-14 2008-08-20 Polichem S.A. Use of chitosans for the treatment of nail inflammatory diseases
DE102010020940B4 (de) * 2010-05-19 2014-09-25 Heraeus Medical Gmbh Antibiotische Beschichtung
CA3019436A1 (en) 2016-03-30 2017-10-05 Qualizyme Diagnostics Gmbh & Co Kg Detecting microbial infection in wounds
EP3436041B1 (en) 2016-03-31 2023-05-24 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
WO2017173240A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
AU2017240064B8 (en) 2016-03-31 2021-11-11 Gojo Industries, Inc. Antimicrobial peptide stimulating sanitizing composition
JP2020500860A (ja) 2016-11-23 2020-01-16 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティック／プレバイオティックな有効成分を含む消毒薬組成物
KR102511613B1 (ko) * 2019-09-23 2023-03-17 포항공과대학교 산학협력단 키토산을 포함하는 면역억제용 조성물 및 이의 용도
CN115996707A (zh) 2020-04-20 2023-04-21 德克萨斯大学系统董事会 生物活性干粉组合物及其制造和使用方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4532134A (en) * 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
CA1261264A (en) * 1984-11-29 1989-09-26 Shigeo Suzuki Immunopotentiating agents and method
IT1275198B (it) * 1992-01-16 1997-07-30 Ecobios Lab Idropittura universale, polivalente, battericida, ignifuga, traspirante ecologica, isolante, antiossidante, desalinizzante delle efflorescenze di salnitro anche di sali igroscopici per manufatti edilizi, legno, metalli e materie plastiche.
US5482843A (en) * 1992-12-14 1996-01-09 Universite De Sherbrooke Enzyme of use in chitosan hydrolysis
US5891861A (en) * 1996-10-15 1999-04-06 Platt; David Composition and method for treating fungal disease in animals
US5981510A (en) * 1997-04-15 1999-11-09 Yaizu Suisankagaku Industry Co., Ltd. Method for treating and improving diabetes
SE508760C2 (sv) * 1997-04-29 1998-11-02 Medicarb Ab Användning av en komposition innefattande kitosan i kombination med en polysackarid, som aktiv komponent i ett lösningsmedel, för framställning av ett spendoppningsmedel för mjölkproducerande djur
US5730876A (en) * 1997-05-30 1998-03-24 Hyang-Ja You Separation and purification of low molecular weight chitosan using multi-step membrane separation process
JP2001055335A (ja) * 1999-08-18 2001-02-27 Toshio Sato アレルギー性皮膚疾患治療剤
EP1127574A1 (en) * 2000-02-22 2001-08-29 Food Industry Research and Development Institute Use of chitinous materials for inhibiting cellular nitric oxide production
US6653294B2 (en) * 2000-02-29 2003-11-25 Food Industry Research & Development Institute Use of chitinous materials for inhibiting cellular nitric oxide production

Also Published As

Publication number Publication date
EP1455802B1 (en) 2008-10-15
AU2002351583A1 (en) 2003-06-30
WO2003051376A1 (en) 2003-06-26
ATE411032T1 (de) 2008-10-15
DE60229431D1 (de) 2008-11-27
SI1455802T1 (sl) 2009-06-30
EP1455802A1 (en) 2004-09-15
US20050004057A1 (en) 2005-01-06
US20070167400A1 (en) 2007-07-19
ES2315417T3 (es) 2009-04-01
PT1455802E (pt) 2008-11-03

Similar Documents

Publication Publication Date Title
DK1455802T3 (da) Anvendelser af chitosanoligosaccharider
CA1210699A (fr) Compositions permettant de combattre les mefaits et les inconvenients de la transpiration
EP4442241A3 (en) Retinol replacement in skin treatment
BRPI0416160A (pt) composições de xampu antimicrobianas
BR9906438A (pt) Composição de reforço nutricional apropriada para o tratamento de úlceras de pressão
AU2903300A (en) Novel pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing medicament or a dietary supplement for thetreatment or prevention of inflammation, hypersensitivity reactions or pain
WO2006032500A3 (en) Immunogenic composition
WO2007084769A3 (en) Microalgae-derived compositions for improving the health and appearance of skin
TR200100610T2 (tr) Asetil L-karnitin ve alfa-lipoik asit içeren antioksidant bileşim
AU2002254396A1 (en) Method of attenuating reactions to skin irritants
WO2006102610A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2009017369A3 (en) Compositions for skin protection and improvement of skin diseases containing the dibenzo-p-dioxine derivatives
MX2009008084A (es) Derivados de 5,6,7,8-tetrahidropteridina como inhibidores de hsp90.
PT942741E (pt) Composicoes de lectina e suas utilizacoes
ZA202307290B (en) Pyrazolopyridine derivatives and uses thereof
WO2007028022A3 (en) Novel compounds as p2x7 modulators and uses thereof
TW200510352A (en) Cycloalkyl substituted amino acid derivatives, processes for their freparation and their use as pharmaceuticals
DE60221155D1 (de) Negatif geladene polysaccharide aus aloe vera
GB9809349D0 (en) Heterocyclic derivatives
ZA201000213B (en) Chitosan carboxyalkylamide hydrogel,preparation thereof and cosmetic and dermatological use thereof
IL141325A0 (en) Tan-1057 derivatives
AU2003246877A8 (en) Cosmetic composition comprising monosaccharides or polysaccharides____________________________________
WO2003002125A3 (en) Combination of aminosugars and cysteine or cysteine derivatives
CA2491027A1 (en) Novel flavone c-glycoside derivatives and compositions containing the derivatives
RU2005140097A (ru) Лекарственное средство для внутреннего применения, в частности, против раковых заболеваний